Skip to main content
Clinical Trials/NCT03998644
NCT03998644
Recruiting
N/A

A Study Focused on the Host and Microbiome of Colorectal Cancer Patients

Shanghai 10th People's Hospital1 site in 1 country2,000 target enrollmentDecember 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Colorectal Neoplasms
Sponsor
Shanghai 10th People's Hospital
Enrollment
2000
Locations
1
Primary Endpoint
Gut microbiota structure and function difference between colorectal cancer, precancer and healthy controls
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

Recruit of healthy, precancer and colorectal cancer patients and record necessary information of demographic and also other messages. All the volunteers were asked to provide samples including stool, blood, urine and tissues. This protocol is performed with the permission of the ethics committee and all the participants were provided with informed consent.

Detailed Description

Healthy subjects, precancer patients identified by colonoscopy or colonoscopy history and colorectal cancer patients identified by two independent pathologists will be enrolled. The demographic message including age, weight, height, drug history, family history of all participants will be recorded. Blood, stool and urine samples will be collected of all subjects. Tumor and adjacent tissue samples of colorectal cancer and precancer patients were collected, as well as normal tissue of healthy subjects.

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
December 2025
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai 10th People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Huanlong Qin

Professor

Shanghai 10th People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Any one who can not provide accurate information.
  • Any one who denies the study.
  • Younger than 18.

Outcomes

Primary Outcomes

Gut microbiota structure and function difference between colorectal cancer, precancer and healthy controls

Time Frame: average of 5 years

The results were based on the 16S rRNA metagenomic sequencing.

Secondary Outcomes

  • Metabolic difference of blood samples between colorectal cancer, precancer and healthy controls(average of 5 years)

Study Sites (1)

Loading locations...

Similar Trials